MISSION BIOCAPITAL
MISSION BIOCAPITAL is a Pre-seed, Seed and Series A fund in the US and Europe writing $25K–$10M checks into AI, therapeutics, diagnostics, medical-devices, laboratory-tools, drug-delivery, genomic-medicine and personalized-medicine.
- Stages
- Pre-seed, Seed, Series A
- Sectors
- AI, therapeutics, diagnostics, medical-devices, laboratory-tools, drug-delivery, genomic-medicine, personalized-medicine
- Check size
- $25K–$10M
- Invests in
- US-wide, Europe
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2009
- Assets under management
- $500M+
Thesis
Mission BioCapital is a venture capital firm founded in 2009 that focuses on early-stage life science companies, particularly in therapeutics, diagnostics, medical devices, laboratory tools, and drug delivery. They have a strong emphasis on genomic and personalized medicine technologies. The firm actively creates companies by collaborating with researchers and entrepreneurs, and offers a supportive platform including shared lab space, operational support, and strategic mentorship. Their 'Platinum Program' provides up to $500,000 in pre-seed funding along with essential services. Mission BioCapital manages over $500 million in assets, with Fund VI closing at $143.75 million and Fund V at $275 million. They can lead investments and typically invest between $25,000 and $10 million per company. Their geographic focus is primarily the United States, with some investments in Europe.
Common questions
Does MISSION BIOCAPITAL invest at the Pre-seed stage?
Yes. MISSION BIOCAPITAL lists Pre-seed, Seed and Series A among the stages it invests in.
What check size does MISSION BIOCAPITAL write?
MISSION BIOCAPITAL writes $25K–$10M checks.
Where does MISSION BIOCAPITAL invest?
MISSION BIOCAPITAL invests in the US and Europe.